Craft

Pharmaron

Stock Price

¥30

2024-10-29

Market Capitalization

¥48.1 B

2024-10-29

Revenue

¥12.2 B

FY, 2024

Pharmaron Summary

Company Summary

Overview
Pharmaron (康龙化成(北京)新药技术股份有限公司) is a company that provides contract research, development, and manufacturing services for pharmaceutical products. It operates in four business segments: Laboratory Services, CMC Services, Clinical Development Services, and Biologics and CGT Services. The Laboratory Services segment includes laboratory chemistry and bioscience services, covering small-molecule drugs, oligonucleotides, peptides, antibodies, antibody-drug conjugates, and CGT products. The CMC Services segment focuses on process development and manufacturing, material science and pre-formulation, formulation development and manufacturing, and analytical development services. The Clinical Development Services segment specializes in radio-labeled science services and early-stage clinical trial services. The Biologics and CGT Services segment comprises biologics discovery, development, and manufacturing services, CGT lab services, and gene therapy CDMO solutions.
Type
Public
Status
Active
Founded
2004
HQ
Beijing, CN | view all locations
Website
https://www.pharmaron.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Boliang Lou
  • Larry Lou
  • Bei Zheng

    Bei Zheng, Executive Vice President

    • Hua Yang

      Hua Yang, Chief Scientific Officer

    Operating MetricsView all

    Projects (CMC Services)

    463

    H1, 2020

    Preclinical Projects (CMC Services)

    292

    H1, 2020

    Phase I Clinical Projects (CMC Services)

    54

    FY, 2019

    LocationsView all

    19 locations detected

    • Beijing, Bei Jing Shi HQ

      China

      6 Taihe Road, BDA

    • Baltimore, MD

      United States

      800 West Baltimore Street

    • Exton, PA

      United States

      436 Creamery Way, Suite 600

    • Germantown, MD

      United States

      20340 Seneca Meadows Parkway

    • Louisville, KY

      United States

      201 E Jefferson St

    • Medford, MA

      United States

      47 Hall St

    and 13 others

    Pharmaron Financials

    Summary Financials

    Revenue (FY, 2024)
    ¥12.2B
    Gross profit (FY, 2024)
    ¥4.1B
    Net income (FY, 2024)
    ¥1.7B
    Cash (FY, 2024)
    ¥1.7B
    EBIT (FY, 2024)
    ¥1.7B
    Enterprise value
    $52.4B

    Footer menu